Treatment Emergent Dolutegravir Resistance Mutations in Individuals Naïve to HIV-1 Integrase Inhibitors: A Rapid Scoping Review

Treatment Emergent Dolutegravir Resistance Mutations in Individuals Naïve to HIV-1 Integrase Inhibitors: A Rapid Scoping Review

<b>Background</b>: Dolutegravir (DTG)-based antiretroviral therapy (ART) rarely leads to virological failure (VF) and drug resistance in integrase strand transfer inhibitor (INSTI)-naïve persons living with HIV (PLWH). As a result, limited data are available on INSTI-associated drug resi...

Full description

Bibliographic Details
Main Authors: Kaiming Tao, Soo-Yon Rhee, Carolyn Chu, Ava Avalos, Amrit K. Ahluwalia, Ravindra K. Gupta, Michael R. Jordan, Robert W. Shafer
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Viruses
Subjects:
Dolutegravir
HIV-1 integrase
antiviral resistance
mutations
Online Access:https://www.mdpi.com/1999-4915/15/9/1932

Internet

https://www.mdpi.com/1999-4915/15/9/1932

Similar Items